Literature DB >> 10080934

Expression of human perlecan domain I as a recombinant heparan sulfate proteoglycan with 20-kDa glycosaminoglycan chains.

L D Graham1, J M Whitelock, P A Underwood.   

Abstract

Recombinant forms of human perlecan domain I were secreted as proteoglycans by stably transfected human 293 cells. A recombinant domain I-only proteoglycan spanned the 95- to 265-kDa region in SDS-PAGE and appeared to be 160 kDa in denaturing gel filtration. Its glycosaminoglycan (GAG) content was approximately 67% heparan sulfate, and its average GAG chain size of 20 kDa suggested that the true molecular mass of the proteoglycan was 90 kDa. Domain I with enhanced green fluorescent protein fused to its C-terminus had an apparent molecular mass of 210-220 kDa and contained approximately 100% heparan sulfate. Its average GAG chain size (also 20 kDa) suggested a true molecular mass of 117 kDa for this proteoglycan. Its sulfate content of 53-77 mol SO2-4 per mole of protein indicated the presence of one sulfate group per 4-7 GAG sugar residues. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10080934     DOI: 10.1006/bbrc.1999.0377

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

Review 1.  Perlecan and tumor angiogenesis.

Authors:  Xinnong Jiang; John R Couchman
Journal:  J Histochem Cytochem       Date:  2003-11       Impact factor: 2.479

2.  Similarity of recombinant human perlecan domain 1 by alternative expression systems bioactive heterogenous recombinant human perlecan D1.

Authors:  April L Ellis; Wensheng Pan; Guang Yang; Kim Jones; Christine Chuang; John M Whitelock; Arthur A DeCarlo
Journal:  BMC Biotechnol       Date:  2010-09-09       Impact factor: 2.563

Review 3.  Modular Proteoglycan Perlecan/HSPG2: Mutations, Phenotypes, and Functions.

Authors:  Jerahme R Martinez; Akash Dhawan; Mary C Farach-Carson
Journal:  Genes (Basel)       Date:  2018-11-16       Impact factor: 4.096

Review 4.  Review of Alterations in Perlecan-Associated Vascular Risk Factors in Dementia.

Authors:  Amanda L Trout; Ibolya Rutkai; Ifechukwude J Biose; Gregory J Bix
Journal:  Int J Mol Sci       Date:  2020-01-20       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.